DESCRIPTION
Frequent description
Agar is a hydrophilic colloid obtained from marine algae (Rhodophyceae). It is soluble in boiling water and is of significance to the microbiological house.
Agar chemically consists of two fractions: agarose, a neutral polymer of extreme gel energy and agaropectin, a non-gelling fraction with sulfated β-1,3-glycosidically linked D-galactose gadgets.
Summary
The commercial exploitation of plant cell, tissue and organ cultures is now a actuality and the model new utilized sciences are already in place and creating shortly. Their emergence has provided new views and sharpened the principle focus of the strategies by which plant cell and tissue custom can help man. Together with the thrilling new developments in plant molecular biology, these in vitro procedures must allow plant bio technologists to ‘design’ crops and plant merchandise and exploit the whole industrial potential of plant cell cultures.
PROPERTIES
Top quality Stage
200
natural provide
algae (Rhodophyceae)
sort
powder
utility(s)
cell custom | mammalian: acceptable
cell custom | plant: acceptable
microbiology: acceptable
transition temp
congealing temperature <38 °C (1.5% in H2O)
suitability
microbiology examined
Featured Enterprise
Agriculture
storage temp.
room temp
Utility
Agar has been used:
- as a reference commonplace industrial agar to match the physio-chemical, gelling properties of alkali-treated agar from Gracilaria tenuistipitata
- as an element inside the seed germination medium and rooting medium for commercially obtainable soybean (Glycine max (L.) Merr) seeds
- as part of improvement media for B. subtilis mutant strain MTC871 based biofilm colonies
- as a bacteriological agar half to rearrange half energy Murashige-Skoog (MS 50%) medium for Echinocactus platycanthus seeds custom
PPM
Agar has been used inside the plant improvement media.
Typical working focus: 6-12g/L.
Typical working focus: 6-12g/L.
Packaging
5, 10, 25 kg in poly drum
1 kg in poly bottle
100, 500 g in poly bottle
Biochem/physiol Actions
Agar is gel forming polysaccharide used as a gelling and stabilizing agent. Its serves as a cryoprotectant in processed meals, prescribed drugs and cosmetics merchandise.
Completely different Notes
Frequent operate agar.
Bacterial Illnesses
Some micro organism inflicting infecting Cannabis crops embrace Pseudomonas syringae and Xanthomonas campestris pv. Cannabis. The indicators of Pseudomonas syringae are small water-soaked leaf spots which is able to enlarge alongside the veins, turning brown. The Xanthomonas campestris causes leaf spots and wilting in crops.
Fungal Illnesses
Just a few of the principle cannabis infecting fungus and illnesses attributable to them are:
- Fusarium oxysporum f.sp. Cannabis causes wilt whose indicators embrace yellowing of leaves, poor improvement, and wilt.
- Pythium sickness causes root rot and damping-off sickness whose indicators fluctuate from small roots lesions, excessive root damage, stunted improvement, to yellowing of leaves. Extra, damping-off impacts youthful seedlings.
- Sclerotinia sclerotiorum causes hemp canker whose preliminary indicators embrace watersoaked lesions on stalks and branches that will later set off cankers. Typically cottony white mycelium and black sclerotia could appear.
- Sphaeorotheca macularis or Leveillula taurica causes powdery mildew. It’s one of many essential widespread foliar illnesses of cannabis. Its indicators embrace powdery improvement on the ground of leaves that later turns brown.
- The cannabis plant will be affected by Alternaria species, which causes leaf spot and brown blight illnesses.
Viral and Viroid Illnesses
Viruses affecting cannabis embrace Hop mosaic virus (HpMV), Apple mosaic virus (ApMV), Hop stunt viroid (HSVd), Hop latent viroid, Arabis mosaic virus (ArMV), Alfalfa mosaic virus (AMV), Tobacco mosaic virus (TMC), Cucumber mosaic virus (CMV), and phytoplasmas.
The viruses could trigger excessive crop losses, reduce improvement, or impact the yield and prime quality of crops. The widespread indicators of viruses embrace yellow and inexperienced mosaic patterns on the leaves of Cannabis and curling, distortion, and narrowing of youthful leaves. Phytoplasmas primarily set off excessive shoot proliferation and stunted improvement.
 Mouse anti-CD273 Antibody |
|||
| DL99420A-100ul | DL Develop | 100 ul | EUR 299 |
|
Description: B7DC; CD273; PDCD1L2; PDL2; Programmed cell death 1 ligand 2; PD-1 ligand 2; PD-L2; PDCD1 ligand 2; Programmed death ligand 2; Butyrophilin B7-DC; B7-DC; CD273 |
|||
Mouse anti-CD273 Antibody |
|||
| DL99420A-50ul | DL Develop | 50 ul | EUR 210 |
|
Description: B7DC; CD273; PDCD1L2; PDL2; Programmed cell death 1 ligand 2; PD-1 ligand 2; PD-L2; PDCD1 ligand 2; Programmed death ligand 2; Butyrophilin B7-DC; B7-DC; CD273 |
|||
Mouse anti-CD273 Antibody |
|||
| DL99442A-100ul | DL Develop | 100 ul | EUR 299 |
|
Description: B7DC; CD273; PDCD1L2; PDL2; Programmed cell death 1 ligand 2; PD-1 ligand 2; PD-L2; PDCD1 ligand 2; Programmed death ligand 2; Butyrophilin B7-DC; B7-DC; CD273 |
|||
Mouse anti-CD273 Antibody |
|||
| DL99442A-50ul | DL Develop | 50 ul | EUR 210 |
|
Description: B7DC; CD273; PDCD1L2; PDL2; Programmed cell death 1 ligand 2; PD-1 ligand 2; PD-L2; PDCD1 ligand 2; Programmed death ligand 2; Butyrophilin B7-DC; B7-DC; CD273 |
|||
 mAb) Mouse Anti-Human CD273 (PD-L2) mAb |
|||
| CM031-100ug | SAB | 100ug | EUR 250.8 |
Mouse Anti-Human CD273 (PD-L2) mAb |
|||
| CM031-25ug | SAB | 25ug | EUR 154.8 |
 PE Anti-Human CD273/PD-L2 Antibody |
|||
| DL21928F-20Tests | DL Develop | 20Tests | EUR 222.5 |
|
Description: CD273, known as B7-DC, is also called programmed death ligand 2 (PDL2). This ligand is a 25 kD type I transmembrane protein and a member of B7 family within the immunoglobulin receptor superfamily and is expressed on a subset of dendritic cells, liver and a small subset of macrophages as well as a few transformed cell lines. CD273 has been reported to be stimulatory on dendritic cells when cross-linked and to inhibit T cell activation upon engaging the PD-1 receptor. CD273 has also been reported to bind to an alternative receptor and to mediate T cell activation through such non-PD1 mediated interactions. |
|||
PE Anti-Human CD273/PD-L2 Antibody |
|||
| DL21928F-50Tests | DL Develop | 50Tests | EUR 320 |
|
Description: CD273, known as B7-DC, is also called programmed death ligand 2 (PDL2). This ligand is a 25 kD type I transmembrane protein and a member of B7 family within the immunoglobulin receptor superfamily and is expressed on a subset of dendritic cells, liver and a small subset of macrophages as well as a few transformed cell lines. CD273 has been reported to be stimulatory on dendritic cells when cross-linked and to inhibit T cell activation upon engaging the PD-1 receptor. CD273 has also been reported to bind to an alternative receptor and to mediate T cell activation through such non-PD1 mediated interactions. |
|||
 APC Anti-Human CD273/PD-L2 Antibody |
|||
| DL21929F-20Tests | DL Develop | 20Tests | EUR 245 |
|
Description: CD273, known as B7-DC, is also called programmed death ligand 2 (PDL2). This ligand is a 25 kD type I transmembrane protein and a member of B7 family within the immunoglobulin receptor superfamily and is expressed on a subset of dendritic cells, liver and a small subset of macrophages as well as a few transformed cell lines. CD273 has been reported to be stimulatory on dendritic cells when cross-linked and to inhibit T cell activation upon engaging the PD-1 receptor. CD273 has also been reported to bind to an alternative receptor and to mediate T cell activation through such non-PD1 mediated interactions. |
|||
APC Anti-Human CD273/PD-L2 Antibody |
|||
| DL21929F-50Tests | DL Develop | 50Tests | EUR 357.5 |
|
Description: CD273, known as B7-DC, is also called programmed death ligand 2 (PDL2). This ligand is a 25 kD type I transmembrane protein and a member of B7 family within the immunoglobulin receptor superfamily and is expressed on a subset of dendritic cells, liver and a small subset of macrophages as well as a few transformed cell lines. CD273 has been reported to be stimulatory on dendritic cells when cross-linked and to inhibit T cell activation upon engaging the PD-1 receptor. CD273 has also been reported to bind to an alternative receptor and to mediate T cell activation through such non-PD1 mediated interactions. |
|||
 Antibody) Programmed Cell Death 1 Ligand 2 (CD273) Antibody |
|||
| abx140405-01mg | Abbexa | 0.1 mg | EUR 427.2 |
Programmed Cell Death 1 Ligand 2 (CD273) Antibody |
|||
| abx412031-01mg | Abbexa | 0.1 mg | EUR 610.8 |
Programmed Cell Death 1 Ligand 2 (CD273) Antibody |
|||
| abx414235-025mg | Abbexa | 0.25 mg | EUR 678 |
Programmed Cell Death 1 Ligand 2 (CD273) Antibody |
|||
| abx414420-02mg | Abbexa | 0.2 mg | EUR 678 |
Programmed Cell Death 1 Ligand 2 (CD273) Antibody |
|||
| abx414421-01mg | Abbexa | 0.1 mg | EUR 526.8 |
, PE Conjugated mAb) Mouse Anti-Human CD273 (PD-L2), PE Conjugated mAb |
|||
| CM033-100T | SAB | 100T | EUR 494.4 |
Mouse Anti-Human CD273 (PD-L2), PE Conjugated mAb |
|||
| CM033-25T | SAB | 25T | EUR 242.4 |
 PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
| R32447 | NSJ Bioreagents | 100 ug | EUR 356.15 |
|
Description: Programmed cell death 1 ligand 2 (also known as PD-L2, B7-DC) is a protein that in humans is encoded by the PDCD1LG2 gene. It is mapped to chromosome 9p24.2. PD-L2 is one of two ligands for programmed death-1 (PD-1), a member of the CD28 family of immuno-receptors. Northern blot analysis detect wide expression of PDL2, with highest levels in placenta, heart, pancreas, lung, and liver, and lower levels in spleen, lymph nodes, and thymus. PDL2 negatively regulates T cells and plays an essential role in immune tolerance. |
|||
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
| V7546-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: PD-L2/PDCD1LG2 is involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production. [UniProt] |
|||
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
| V7546-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
|
Description: PD-L2/PDCD1LG2 is involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production. [UniProt] |
|||
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
| V7546SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: PD-L2/PDCD1LG2 is involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production. [UniProt] |
|||
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
| V7581-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: Recognizes a protein identified as PD-L2 (same as PDCD1LG2). Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T cell proliferation, cytokine production, differentiation of effector T cells and the induction of Bcl-x, a promoter of T cell survival. Conversely, engagement of CTLA4 by B7-1 or B7-2 may inhibit proliferation and IL-2 production. PD-L2 does not bind CD28, cytotoxic T lymphocyte A4 or ICOS (inducible co-stimulator). The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the Pdcd-1-Pdcd-L system could provide unique negative signaling to help prevent autoimmune disease. |
|||
